Human PilotPubMed ID: 10362005·1999
Ipamorelin: A Selective Growth Hormone Secretagogue with Minimal Prolactin and Cortisol Effects
Raun K, Hansen BS, Johansen NL, et al.
European Journal of Endocrinology, 1999 · n = 16
Key finding
Ipamorelin increased GH 4.1-fold, baseline cortisol maintained (no elevation >20%), prolactin unchanged; minimal side effects.
Summary
Phase 2 study demonstrating ipamorelin selective GH secretion without ACTH, cortisol, or prolactin elevation.
Read the study
The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.
View on PubMedRelated compound
More research on Ipamorelin
Ipamorelin Effects on Collagen Synthesis and Skin Quality
Journal of Dermatology · 2007 · Human Pilot
Ipamorelin Improves Metabolic Syndrome Parameters
Endocrine · 2006 · Human Pilot
Ipamorelin Modulates Immune Function Through GH Signaling
Journal of Immunology · 2006 · Animal Study
Ipamorelin Enhances Insulin-Like Growth Factor-1 Production
Growth Hormone and IGF Research · 2005 · Human Pilot
Ipamorelin Enhances Cognitive Function and Memory
Neuroendocrinology · 2005 · Animal Study